Christopher E. Mason
#185,838
Most Influential Person Now
Christopher E. Mason's AcademicInfluence.com Rankings
Christopher E. Masonbiology Degrees
Biology
#15629
World Rank
#19654
Historical Rank
Genetics
#1845
World Rank
#1961
Historical Rank

Download Badge
Biology
Christopher E. Mason's Degrees
- Bachelors Genetics University of California, Berkeley
Why Is Christopher E. Mason Influential?
(Suggest an Edit or Addition)Christopher E. Mason's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- A brief definition of regenerative medicine. (2008) (627)
- Lancet Commission: Stem cells and regenerative medicine (2017) (159)
- Cell therapy industry: billion dollar global business with unlimited potential. (2011) (152)
- Peak serum: implications of serum supply for cell therapy manufacturing. (2012) (119)
- Regenerative medicine cell therapies: numbers of units manufactured and patients treated between 1988 and 2010. (2010) (115)
- Activation of Pluripotency Genes in Human Fibroblast Cells by a Novel mRNA Based Approach (2010) (114)
- Mechanical dynamics of single cells during early apoptosis. (2009) (98)
- The potential of optical coherence tomography in the engineering of living tissue. (2004) (90)
- Regenerative medicine bioprocessing: building a conceptual framework based on early studies. (2006) (78)
- Bioprocess Forces and Their Impact on Cell Behavior: Implications for Bone Regeneration Therapy (2011) (75)
- The impact of manual processing on the expansion and directed differentiation of embryonic stem cells (2008) (74)
- Regenerative medicine 2.0. (2007) (68)
- A decade of cell therapy clinical trials (2000-2010). (2012) (67)
- Assessing the value of autologous and allogeneic cells for regenerative medicine. (2009) (64)
- International community consensus standard for reporting derivation of human embryonic stem cell lines. (2007) (59)
- Hypoxia enhances the generation of retinal progenitor cells from human induced pluripotent and embryonic stem cells. (2012) (56)
- Positioning a Scientific Community on Unproven Cellular Therapies: The 2015 International Society for Cellular Therapy Perspective. (2015) (52)
- Regenerative medicine bioprocessing: the need to learn from the experience of other fields. (2006) (51)
- Cell therapy medical tourism: time for action. (2010) (50)
- Doppler optical coherence tomography for measuring flow in engineered tissue. (2004) (50)
- What Is the Greatest Regulatory Challenge in the Translation of Biomaterials to the Clinic? (2012) (50)
- The effect of Young's modulus on the neuronal differentiation of mouse embryonic stem cells. (2015) (47)
- Quantities of cells used for regenerative medicine and some implications for clinicians and bioprocessors. (2009) (47)
- Corneal epithelial stem cells in health and disease (2006) (45)
- Engineering Efficient Retinal Pigment Epithelium Differentiation From Human Pluripotent Stem Cells (2014) (44)
- Scale-up of human embryonic stem cell culture using a hollow fibre bioreactor (2012) (44)
- Mapping correlated membrane pulsations and fluctuations in human cells (2007) (43)
- Regen: the industry responsible for cell-based therapies. (2009) (39)
- The strong financial case for regenerative medicine and the regen industry. (2008) (38)
- Part 1: Defining unproven cellular therapies. (2016) (36)
- Proposal for a universal minimum information convention for the reporting on the derivation of human embryonic stem cell lines. (2006) (33)
- The impact of market volatility on the cell therapy industry. (2011) (32)
- Induced pluripotent stem cells: an emerging technology platform and the Gartner hype cycle. (2009) (29)
- The global cell therapy industry continues to rise during the second and third quarters of 2012. (2012) (28)
- Preimplantation genetic diagnosis as a source of human embryonic stem cells for disease research and drug discovery (2009) (27)
- Viscoelastic, physical, and bio-degradable properties of dermal scaffolds and related cell behaviour (2016) (25)
- Reproducible culture and differentiation of mouse embryonic stem cells using an automated microwell platform☆ (2013) (23)
- Cell therapy worldwide: an incipient revolution. (2015) (23)
- Cost of Stem Cell-Based Tissue-Engineered Airway Transplants in the United Kingdom: Case Series. (2016) (23)
- Cell therapy companies make strong progress from October 2012 to March 2013 amid mixed stock market sentiment. (2013) (19)
- Defeating stem cell tourism. Foreword. (2010) (19)
- Effect of Sub-Atmospheric Oxygen on the Culture of Rabbit Limbal Epithelial Cells (2011) (18)
- Turning Regenerative Medicine Breakthrough Ideas and Innovations into Commercial Products. (2015) (18)
- The Translation Cycle: round and round in cycles is the only way forward for regenerative medicine. (2010) (18)
- The full spectrum of physiological oxygen tensions and step‐changes in oxygen tension affects the neural differentiation of mouse embryonic stem cells (2011) (16)
- The 3Rs of Cell Therapy (2016) (16)
- Precisely delivered nanomechanical forces induce blebbing in undifferentiated mouse embryonic stem cells (2011) (16)
- Effect of capillary shear stress on recovery and osteogenic differentiation of muscle‐derived precursor cell populations (2011) (14)
- Stem cell nations working together for a stem cell world. (2010) (14)
- New era dawns for US stem cell research. (2009) (14)
- Human embryonic stem cell therapy in the post-Geron era. (2012) (13)
- Lessons for the nascent regenerative medicine industry from the biotech sector. (2007) (13)
- The need for a regen industry voice. (2008) (13)
- Promising growth and investment in the cell therapy industry during the first quarter of 2012. (2012) (13)
- Regenerative medicine. The industry comes of age. (2007) (13)
- Automated tissue engineering: a major paradigm shift in health care. (2003) (12)
- Tissue engineering skin: a paradigm shift in wound care. (2005) (12)
- Translational regenerative medicine research: essential to discovery and outcome. (2007) (12)
- The time has come to engineer tissues and not just tissue engineer. (2006) (11)
- Streamlining Cell Therapy Manufacture (2012) (11)
- The crucial linkage required between regenerative medicine bioprocessors and clinicians. (2008) (10)
- Design of a Novel Two-Component Hybrid Dermal Scaffold for the Treatment of Pressure Sores. (2017) (10)
- Hypoxic culture of human pluripotent stem cell lines is permissible using mouse embryonic fibroblasts. (2012) (10)
- Donor Variability in Growth Kinetics of Healthy hMSCs Using Manual Processing: Considerations for Manufacture of Cell Therapies. (2018) (10)
- ISSCR 2009 Industry Panel Session: promoting translation and commercialization. (2009) (9)
- Method for estimating protein binding capacity of polymeric systems (2015) (8)
- Directed Differentiation of Embryonic Stem Cells Using a Bead-Based Combinatorial Screening Method (2014) (7)
- Cells: from Robert Hooke to cell therapy—a 350 year journey (2015) (6)
- Evolving Industry Partnerships and Investments in Cell and Gene Therapies. (2018) (6)
- Cell therapy commercialisation (2012) (6)
- Pharmaceutical industry: Investors unfazed by drug-patent expiry (2012) (5)
- Evolving Industry Partnerships and Investments in Cell and Gene Therapies. (2018) (5)
- 'The Little Purple Book': BSI glossary of regenerative medicine. Foreword. (2009) (5)
- Mapping the human embryome: 1 to 10e13 and all the cells in between. (2007) (5)
- Stem cells are big news, but are they big business? (2005) (5)
- Bioprocessing strategies to enhance the challenging isolation of neuro-regenerative cells from olfactory mucosa (2018) (5)
- Enabling advanced cell therapies (EnACT): invitation to an online forum on resolving barriers to clinical translation. (2012) (5)
- Oxygen-controlled automated neural differentiation of mouse embryonic stem cells. (2013) (5)
- 'The Little Purple Book', 2nd edition: Cell therapy and regenerative medicine glossary. (2012) (5)
- A novel filtration system for point of care washing of cellular therapy products (2017) (5)
- Regenerative medicine: revolution in the making. (2005) (4)
- A novel filtration device for point of care preparation of cellular therapies (2015) (4)
- Influence of Initial Seeding Density on Gene Expression during Neuronal Priming (2015) (4)
- Cell & Gene Therapy, and Regenerative Medicine – Different Definitions (2016) (4)
- Cell Therapy Regulatory Toolkit: an online regulatory resource. (2015) (4)
- Altered hMSC functional characteristics in short-term culture and when placed in low oxygen environments: implications for cell retention at physiologic sites. (2014) (3)
- Generation of c-MycERTAM-transduced human late-adherent olfactory mucosa cells for potential regenerative applications (2019) (3)
- Albumin removal from human fibrinogen preparations for manufacturing human fibrin-based biomaterials (2015) (2)
- Stem cell prospects (2008) (2)
- The 3Rs of Cell Therapy. (2016) (2)
- The Korean stem cell fiasco: shifting the focus. (2006) (2)
- Revolutionary therapies for diabetes--catalysts for change. Foreword. (2009) (2)
- Precisely delivered nano-mechanical forces induce blebbing in undifferentiated mouse embryonic stem cells (2011) (1)
- Scale-up of human embryonic stem cell culture using a hollow fibre bioreactor (2012) (1)
- Bioaesthetics and regenerative medicine. (2009) (1)
- Other approaches to fighting cardiovascular disease: stem cells and engineered tissue. (2006) (1)
- A new cell therapy sector arising from the convergence of cell and gene therapy (2013) (1)
- Streamlining Cell Therapy ManufactureClinical to Commercial Scale (2012) (1)
- A changing time: the International Society for Cellular Therapy embraces its industry members. (2010) (1)
- Methods employing cells derived from adult bone marrow (2003) (1)
- A platform for predictive bioprocessing of autologous cells for therapy based on automated microwell cultures (2008) (1)
- The effect of microwell size and inoculation density on the automated processing of stem cells (2006) (0)
- Introducing the special focus issue: cellular reprogramming and iPS cells. (2010) (0)
- Time to move away from the ‘your process is your product’ paradigm? (2016) (0)
- Atomic force microscopy and con-focal imaging of living cells and tissues (2006) (0)
- A US Cell Therapy Regulatory Toolkit (2015) (0)
- High-resolution cellular and molecular follow up of lysosomal disease patients treated with hematopoietic stem cell lentiviral gene therapy (2022) (0)
- Human Embryonic Stem Cells: Derivation and Culture (2008) (0)
- A dynamic oscillation in cell membrane stiffness is an early indicator of apoptosis in human cells (2006) (0)
- Study of a novel tube forming method for preparing engineered blood vessels (2012) (0)
- Cost of stem cell-based tissue-engineered airway transplants in the UK: Case series (2015) (0)
- High-throughput characterization of hematopoietic stem cell engraftment after intravenous and intracerebroventricular dosing. (2022) (0)
- The response of embryonic stem cells to extra-cellular forces (2008) (0)
- Genetically engineered microglia-like cells have therapeutic potential for neurodegenerative disease (2021) (0)
- Long-term hematopoietic stem cell lentiviral gene therapy rescues neuromuscular manifestations in preclinical study of Pompe disease mice (2022) (0)
- 452. RegenVOX - Translational Exploitation Strategy for Stem Cell-Based Tissue-Engineered Laryngeal Implants Undergoing Phase I/II Clinical Trial (2016) (0)
- Bioprocessing strategies to enhance the challenging isolation of neuro-regenerative cells from olfactory mucosa (2018) (0)
- Stem cells: the blue print for the future. (2006) (0)
- Spotlight on : Translation and applications of gene editing (2015) (0)
- REGENVOX: A phase I/II clinical trial of stem cell-based tissue-engineered laryngeal implants. (2015) (0)
- Kanazawa Workshop on Atomic Force Microscopy (2007) (0)
- Intermediate Oxygen Tensions Promote Maintenance and Expansion of the Limbal Epithelial Stem Cell Phenotype (2009) (0)
- Flow Cytometry Assay to Monitor Effectiveness of Gene Therapy Correction in Peripheral Blood Mononuclear Cells of Gaucher Disease Type I Patients (2018) (0)
- The automation of stem cell bioprocessing - prelimiary studies comparing human mesenchymal stem cell and mouse embryinic stem cell expansion (2006) (0)
- Peak Supply: Implications of Serum and Consumable Availability for Clinicians, Researchers, and Commercial Translation (2012) (0)
- Cell Therapy Industry Market Characteristics: Implications for Clinicians, Investors, Patients and Translational Researchers (2012) (0)
- A Comprehensive High Resolution Scrna-Seq Analytical Platform for Characterizing Human Hematopoietic Stem/Progenitor Cells States in Ex Vivo Drug Products (2020) (0)
- Controlling the embryonic stem cell microenvironment in culture: inherent variations associated with manual handling and opportunities for automation (2007) (0)
- The Effect of Human Embryonic Stem Cell Seeding Density on the Timing and Yield of Differentiation into Retinal Pigment Epithelium (2011) (0)
- Leading the way in bringing gene therapy to the CNS with conditioning: a renaissance for busulfan? (2020) (0)
- The Integration of Manufacturing and Delivery into Healthcare Systems (2016) (0)
- Preliminary studies in the automation of stem cell bioprocessing (2006) (0)
- Advanced cell therapies – progress towards the clinic (2016) (0)
- Reprogramming cell fate using mRNA of defined factors (2008) (0)
- Automated approaches to stem cell culture for drug discovery and cell therapy (2008) (0)
- High throughput monitoring of safety, potency and stability of gene therapy cell products in lysosomal disease patients (2022) (0)
- IMPROVING YIELD AND EXPANSION OF PRIMARY OLFACTORY ENSHEATHING CELLS TO GENERATE STABLE CELL LINES FOR SPINAL CORD INJURY (2014) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Christopher E. Mason?
Christopher E. Mason is affiliated with the following schools: